Indeed, therapeutic intervention at each step of the NF-κB pathway (i.e., Cellular Inhibitor of Apoptosis Protein (cIAPs), CBM and IKK complexes, IκBs, and c-Rel) was shown to enhance cancer immunity to some extent. This evidence concerns the gene NFKB1 and cancer.